About
Thaher Pelaseyed is the co-founder and Chief Executive Officer of MucoLife Therapeutics, where the company develops treatments for mucus-related lung diseases including COPD, cystic fibrosis, and asthma. He has over 20 years of research experience in cell and mucin biology and leads a lab within the Mucin Biology Groups at the University of Gothenburg. His lab studies the molecular mechanisms of transmembrane mucins in the epithelial defense against gut microbiota, with applications to inflammatory bowel disease.
Co-founder & Chief Executive Officer at Mucolife
Intro paths
In turn, Thaher can intro founders to Mucolife's investors below.
Mucolife's investors · 1
Co-founders at Mucolife

Experience
- MucoLife TherapeuticsChief Executive Officercurrent2024 — presentGothenburg, Västra Götaland County, Sweden
- Sahlgrenska Academy at University of GothenburgDocentcurrent2023 — presentGothenburg, Vastra Gotaland County, Sweden
- University of GothenburgAssistant Professorcurrent2018 — presentGothenburg, Sweden
- University of GothenburgResearchercurrent2017 — presentGothenburg, Sweden
- University of GothenburgWenner-Gren Research Fellow2017 — 2018Gothenburg, Sweden
- Cornell UniversityPostdoctoral Associate2014 — 2017Ithaca, New York Area
- Sahlgrenska Academy at Gothenburg UniversityPostdoctoral Researcher2012 — 2013Gothenburg, Sweden
- Sahlgrenska Academy at Gothenburg UniversityPhD Student2005 — 2012Sweden
- University of GothenburgMaster Degree of Medicine in Pharmaceutical Bioscience2001 — 2006Gothenburg, Vastra Gotaland County, Sweden
- Sahlgrenska University HospitalLaboratory Techincian2004 — 2006
- Chalmers University of TechnologyMaster's program in Chemical Engineering1999 — 2001Gothenburg, Vastra Gotaland County, Sweden
Skills & more
+12 more
BiochemistryCell CultureScienceResearchRT-PCRIn VitroWestern BlottingTeachingELISAImmunohistochemistryMicroscopyPCRLanguages English · Persian · Swedish
- American Heart Association BLS (CPR and AED) — American Heart Association
From Thaher's professional profile.
Frequently asked questions
- Who is Thaher Pelaseyed?
- Thaher Pelaseyed is the co-founder and Chief Executive Officer of MucoLife Therapeutics, where the company develops treatments for mucus-related lung diseases including COPD, cystic fibrosis, and asthma. He has over 20 years of research experience in cell and mucin biology and leads a lab within the Mucin Biology Groups at the University of Gothenburg. His lab studies the molecular mechanisms of transmembrane mucins in the epithelial defense against gut microbiota, with applications to inflammatory bowel disease.
- Where does Thaher Pelaseyed work?
- Thaher Pelaseyed is Co-founder & Chief Executive Officer of Mucolife.
- What companies did Thaher Pelaseyed found?
- Thaher Pelaseyed founded Mucolife.
- Where did Thaher Pelaseyed go to school?
- Thaher Pelaseyed studied at School of Business, Economics and Law at the University of Gothenburg (Master of Business Administration, Executive Business Administration); University of Gothenburg (Doctor of Philosophy (Ph.D.), Medical Biochemistry); University of Gothenburg (MSc, Biochemistry).
Are you in our directory? — or find your own page and tap it there to see your paths to every investor.
Founder mafias
Cornell mafia534
Also came through, then founded or led a company.
+ 527 more
Chalmers University of Technology mafia48
Also came through, then founded or led a company.
+ 41 more
University of Gothenburg mafia14
Also came through, then founded or led a company.
+ 7 more
School of Business, Economics and Law at the University of Gothenburg mafia9
Also came through, then founded or led a company.
+ 2 more
Same school
Also attended School of Business, Economics and Law at the University of Gothenburg46
+ 40 more
Also attended University of Gothenburg69
+ 63 more
Also attended Chalmers University of Technology97
+ 91 more
Shared employers
Also worked at Sahlgrenska Academy at University of Gothenburg3
Also worked at University of Gothenburg11
+ 5 more
Also worked at Cornell University185
+ 179 more














































